Clinical Trials

Clinical Trials

10
Biological Clock Dysfunction in Optic Nerve Hypoplasia
Disease/Condition: Biological Clock Dysfunction | Optic Nerve Hypoplasia
Principal Investigator: Rivkees, Scott A
CHG Dressings in Children With Central Lines
Disease/Condition: Children With Central Venous Access
Principal Investigator: John Giuliano, Jr.
Effectiveness of Paricalcitol in Reducing Parathyroid Hormone Levels in X-linked Hypophosphatemic Rickets
Disease/Condition: Hyperparathyroidism | Hypophosphatemia, Familial
Principal Investigator: Thomas Carpenter
Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients
Disease/Condition: Paediatric Liver Transplant Recipients
Principal Investigator: Manuel Rodriguez-Davalos
Family-specific Genetic Variants Contributing to Asthma Susceptibility
Disease/Condition: Asthma
Principal Investigator: Andrew DeWan
Guanfacine for Children with Tic Disorders
Disease/Condition: Chronic Motor Tic Disorder | Chronic Vocal Tic Disorder | Tourette Syndrome
Principal Investigator: Lawrence D Scahill
Hepatic De Novo Lipogenesis (DNL)in the Pathogenesis of Hepatic Steatosis in Obese Youth
Disease/Condition: Fatty Liver | Hepatic Steatosis
Principal Investigator: Nicola Santoro
Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis
Disease/Condition: Cystic Fibrosis
Principal Investigator: Marie Egan
Mindfulness Interventions and Chronic Widespread Pain in Adolescents
Disease/Condition: juvenile fibromyalgia
Principal Investigator: Ather Ali
N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder
Disease/Condition: Obsessive Compulsive Disorder
Principal Investigator: Michael Bloch
Neurofeedback for Tourette Syndrome
Disease/Condition: Chronic Tic Disorder | Tourette Syndrome
Principal Investigator: Michelle Hampson
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
Disease/Condition: Diabetes Mellitus, Type 1
Principal Investigator: Kevan Herold
Parent-Adolescent Interactions and Adolescent Development
Disease/Condition: Substance Abuse
Principal Investigator: Tara Chaplin, Ph.D.
Pharmacokinetic Study of CYCLOSET ® 0.8 mg Tablets in Children and Adolescent Type 2 Diabetes Mellitus Subjects
Disease/Condition: Type 2 Diabetes
Principal Investigator: William Tamborlane
RISE Pediatric Medication Study
Disease/Condition: Prediabetes | Type 2 Diabetes
Principal Investigator: Sonia Caprio
Safety and Pharmacokinetic Study of Oral Morphine Sulfate in Pediatric Subjects
Disease/Condition: Pain
Principal Investigator: Haleh Saadat, MD
Stage I Randomized Trial of Mentalization-Based Therapy for Substance Using Mothers of Infants and Toddlers
Disease/Condition: Child Abuse and Neglect | Maternal Substance Abuse
Principal Investigator: Nancy Suchman
Study of KRN23, a Humanized Anti-FGF23 Monoclonal Antibody, in Pediatric Subjects With X-linked Hypophosphatemia (XLH)
Disease/Condition: X-linked Hypophosphatemia
Principal Investigator: Thomas Carpenter
Study to Investigate the Pathophysiology of Type 2 Diabetes in Youth
Disease/Condition: Beta-cell Function | Childhood Obesity | Impaired Glucose Tolerance | Insulin Resistance | Metabolic Syndrome | Pre-Diabetes
Principal Investigator: Sonia Caprio
The genetic effect on omega 3 fatty acid supplementation for the treatment of non alcoholic fatty liver disease in obese children and adolescents
Disease/Condition: Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1 | Hypertriglyceridemia | Non Alcoholic Fatty Liver Disease | Steatohepatitis
Principal Investigator: Nicola Santoro
Why Are Patients With Absence Seizures Absent? A Brain Imaging Study
Disease/Condition: Childhood Absence Epilepsy
Principal Investigator: Hal Blumenfeld